1366 related articles for article (PubMed ID: 19463580)
21. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
Nakamori M; Iwahashi M; Nakamura M; Yamaue H
J Surg Oncol; 2003 Sep; 84(1):10-6. PubMed ID: 12949985
[TBL] [Abstract][Full Text] [Related]
22. Pattern of relapse in surgical treated patients with thoracic esophageal squamous cell carcinoma and its possible impact on target delineation for postoperative radiotherapy.
Cai WJ; Xin PL
Radiother Oncol; 2010 Jul; 96(1):104-7. PubMed ID: 20605246
[TBL] [Abstract][Full Text] [Related]
23. The role of salvage surgery for recurrence of esophageal squamous cell cancer.
Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Setoyama T; Uenosono Y; Ishigami S; Owaki T; Aikou T
Eur J Surg Oncol; 2006 Jun; 32(5):544-7. PubMed ID: 16567077
[TBL] [Abstract][Full Text] [Related]
24. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma.
Bédard EL; Inculet RI; Malthaner RA; Brecevic E; Vincent M; Dar R
Cancer; 2001 Jun; 91(12):2423-30. PubMed ID: 11413534
[TBL] [Abstract][Full Text] [Related]
25. A prospective trial for avoiding cervical lymph node dissection for thoracic esophageal cancers, based on intra-operative genetic diagnosis of micrometastasis in recurrent laryngeal nerve chain nodes.
Miyata H; Yano M; Doki Y; Yasuda T; Yoshioka S; Sugita Y; Takiguchi S; Fujiwara Y; Monden M
J Surg Oncol; 2006 May; 93(6):477-84. PubMed ID: 16615150
[TBL] [Abstract][Full Text] [Related]
26. Subcarinal node metastasis in thoracic esophageal squamous cell carcinoma.
Liu J; Hu Y; Xie X; Fu J
Ann Thorac Surg; 2012 Feb; 93(2):423-7. PubMed ID: 22178587
[TBL] [Abstract][Full Text] [Related]
27. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy.
Fujita H; Sueyoshi S; Yamana H; Shinozaki K; Toh U; Tanaka Y; Mine T; Kubota M; Shirouzu K; Toyonaga A; Harada H; Ban S; Watanabe M; Toda Y; Tabuchi E; Hayabuchi N; Inutsuka H
World J Surg; 2001 Apr; 25(4):424-31. PubMed ID: 11344392
[TBL] [Abstract][Full Text] [Related]
28. [A prospective study of combined chemoradiotherapy followed by surgery in the treatment of esophageal carcinoma].
An FS; Huang JQ; Xie YT; Chen SH; Rong TH
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):376-9. PubMed ID: 12921571
[TBL] [Abstract][Full Text] [Related]
29. Radiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinoma.
Lu JC; Kong C; Tao H
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):710-4. PubMed ID: 20172661
[TBL] [Abstract][Full Text] [Related]
30. [Surgical treatment and prognosis in patients with squamous cell carcinoma of thoracic esophagus].
Zhang DK; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Ma GW; Zhu ZH; Dai Y; Rong TH
Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(17):1333-6. PubMed ID: 19094566
[TBL] [Abstract][Full Text] [Related]
31. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
Mariette C; Taillier G; Van Seuningen I; Triboulet JP
Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
[TBL] [Abstract][Full Text] [Related]
32. Recurrent esophageal carcinoma after esophagectomy with three-field lymph node dissection.
Kato H; Tachimori Y; Watanabe H; Igaki H; Nakanishi Y; Ochiai A
J Surg Oncol; 1996 Apr; 61(4):267-72. PubMed ID: 8627996
[TBL] [Abstract][Full Text] [Related]
33. Prediction of lymph node status in superficial esophageal carcinoma.
Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
[TBL] [Abstract][Full Text] [Related]
34. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M
Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
[TBL] [Abstract][Full Text] [Related]
35. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
Yano T; Muto M; Hattori S; Minashi K; Onozawa M; Nihei K; Ishikura S; Ohtsu A; Yoshida S
Endoscopy; 2008 Sep; 40(9):717-21. PubMed ID: 18773340
[TBL] [Abstract][Full Text] [Related]
36. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
[TBL] [Abstract][Full Text] [Related]
38. Survival after esophageal resection for carcinoma: the importance of the histologic cell type.
Alexiou C; Khan OA; Black E; Field ML; Onyeaka P; Beggs L; Duffy JP; Beggs DF
Ann Thorac Surg; 2006 Sep; 82(3):1073-7. PubMed ID: 16928541
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic efficacy evaluation of postoperative adjuvant radiotherapy in mid-thoracic esophageal carcinoma patients underwent Ivor Lewis esophagectomy with two-field lymphadenectomy.
Yu Y; Wang Z; Yang Z; Liu XY
Med Oncol; 2015 Feb; 32(2):348. PubMed ID: 25572804
[TBL] [Abstract][Full Text] [Related]
40. Causes of death and pattern of recurrence after esophagectomy and extended lymphadenectomy for squamous cell carcinoma of the thoracic esophagus.
Osugi H; Takemura M; Higashino M; Takada N; Lee S; Ueno M; Tanaka Y; Fukuhara K; Hashimoto Y; Fujiwara Y; Kinoshita H
Oncol Rep; 2003; 10(1):81-7. PubMed ID: 12469149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
